Non-small Cell Lung Cancer
📧 Sign up to get email alerts when something new happens for Non-small Cell Lung Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2017-03-09Clinical Trial Update: Expanded Access Study of Alectinib for Participants With Anaplastic Lymphoma Kinase (ALK)-Rearranged Non-Small Cell Lung Cancer (NSCLC) After Disease Progression on or Intolerance to Prior ALK Tyrosine Kinase Inhibitor Therapy
Expanded Access study of Alectinib for ALK-rearranged non-small cell lung cancer after progression on or intolerance to prior ALK inhibitors…
-
CLINICAL_TRIALS trial_result · 2017-03-07Clinical Trial Update: Trial of MEK Inhibitor and PI3K/mTOR Inhibitor in Subjects With Locally Advanced or Metastatic Solid Tumors [Phase 1]
Phase 1 trial evaluating a MEK inhibitor combined with a PI3K/mTOR inhibitor in subjects with locally advanced or metastatic solid tumors; r…
-
CLINICAL_TRIALS research · 2017-03-07Clinical Trial Update: Veristrat as Predictor of Benefit of First Line Non Small Cell Lung Cancer (NSCLC) Patients From Standard Chemotherapy
A clinical trial evaluating whether Veristrat, a biomarker test, can predict which patients with non-small cell lung cancer will benefit fro…
-
CLINICAL_TRIALS research · 2017-03-07Clinical Trial Update: Metformin Plus TKI Use in Patients With Non-Small Cell Lung Carcinoma [NA]
This document reports a clinical trial update testing metformin in combination with a tyrosine kinase inhibitor for Non-Small Cell Lung Canc…
-
CLINICAL_TRIALS trial_result · 2017-03-06Clinical Trial Update: Phase 2 Trial of Bevacizumab in Combination With Pemetrexed [Phase 2]
This document reports the results of a Phase 2 trial evaluating bevacizumab in combination with pemetrexed for non-small cell lung cancer, w…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2017-03-06Clinical Trial Update: Radiation Therapy or Observation After Chemotherapy in Treating Patients With Stage IV Non-Small Cell Lung Cancer [Phase 2]
This clinical trial update notes the termination of a Phase 2 study comparing Radiation Therapy versus Observation after chemotherapy in pat…
-
CLINICAL_TRIALS trial_result · 2017-03-06Clinical Trial Update: Prophylactic Cranial Irradiation (PCI) Versus no PCI in Non Small Cell Lung Cancer After a Response to Chemotherapy [Phase 3]
Phase 3 trial comparing prophylactic cranial irradiation versus no PCI in non-small cell lung cancer patients after chemotherapy response; t…
-
CLINICAL_TRIALS trial_result · 2017-03-03Clinical Trial Update: Efficacy/Safety of Imprime PGG® Injection With Bevacizumab and Paclitaxel/Carboplatin in Patients With Untreated Advanced Non-Small Cell Lung Cancer (NSCLC) [Phase 2]
Phase 2 trial evaluating the efficacy and safety of combining Imprime PGG with Bevacizumab and Paclitaxel/Carboplatin in adults with untreat…
-
CLINICAL_TRIALS trial_result · 2017-03-03Clinical Trial Update: Study of Panobinostat in Combination With Sorafenib in Kidney, Soft Tissue or Lung Cancers [Phase 1]
Phase 1 study assessing the combination of panobinostat with sorafenib in renal cell carcinoma, soft tissue sarcoma, and non-small cell lung…
-
CLINICAL_TRIALS trial_result · 2017-03-03Clinical Trial Update: TAilored Post-Surgical Therapy in Early Stage NSCLC [Phase 2, Phase 3]
Phase 2/3 trial evaluating tailored post-surgical therapy for early-stage non-small cell lung cancer has completed.
-
CLINICAL_TRIALS trial_result · 2017-03-03Clinical Trial Update: Chemotherapy and Erlotinib for Lung Cancer With Low Abundance Epidermal Growth Factor Receptor Mutation [Phase 2]
A Phase 2 trial investigating the combination of chemotherapy and erlotinib for non-small cell lung cancer with low-abundance EGFR mutations…
-
CLINICAL_TRIALS research · 2017-03-03Clinical Trial Update: A FRENCH SURVEY OF THE DIAGNOSTIC AND THERAPEUTIC MANAGEMENT OF ELDERLY PEOPLE WITH HISTOLOGICALLY/CYTOLOGICALLY CONFIRMED LUNG CANCER.
This completed French survey assesses how elderly patients with histologically or cytologically confirmed non-small cell lung cancer are dia…
-
CLINICAL_TRIALS trial_result · 2017-03-03Clinical Trial Update: Predictors of Radiation Pneumonitis in Locally Advanced Lung Cancer Treated With Chemoradiation
The study reports predictors of radiation pneumonitis in patients with locally advanced non-small cell lung cancer treated with chemoradiati…
-
CLINICAL_TRIALS other · 2017-03-03Clinical Trial Update: Clinical Trial on the Prevention of Thrombocytopenia After First-line Chemotherapy [Phase 2, Phase 3]
The document updates a Phase 2/3 clinical trial aimed at preventing thrombocytopenia after first-line chemotherapy in non-small cell lung ca…
-
CLINICAL_TRIALS trial_result · 2017-03-01Clinical Trial Update: Erlotinib Hydrochloride With or Without Celecoxib in Treating Patients With Stage IIIB-IV Non-Small Cell Lung Cancer [Phase 2]
Phase 2 trial evaluating erlotinib with or without celecoxib in Stage IIIB-IV non-small cell lung cancer has completed and results posted.
-
CLINICAL_TRIALS trial_result · 2017-03-01Clinical Trial Update: Phase III Trial to Evaluate the Elortinib vs Gefitinib in Advanced NSCLC With EGFR Exon 19 or 21 Mutations [Phase 3]
Phase III trial comparing Elortinib to Gefitinib in adults with advanced non-small cell lung cancer harboring EGFR exon 19 or 21 mutations h…
-
CLINICAL_TRIALS trial_result · 2017-03-01Clinical Trial Update: Icotinib or Whole Brain Irradiation in EGFR-mutant Lung Cancer [Phase 3]
A Phase 3 randomized trial comparing icotinib with whole brain irradiation in patients with EGFR-mutant non-small cell lung cancer and brain…
-
CLINICAL_TRIALS trial_result · 2017-03-01Clinical Trial Update: A Prospective Epidemiologic Study of ALK-Positive NSCLC in China
A completed prospective epidemiologic study examining ALK-positive non-small cell lung cancer in China, summarizing prevalence and patient c…
-
CLINICAL_TRIALS trial_result · 2017-03-01Clinical Trial Update: A Randomized, Open-label, Multicenter, Phase 3 Study to Compare the Efficacy and Safety of Eribulin With Treatment of Physician's Choice in Subjects With Advanced Non-Small Cell Lung Cancer [Phase 3]
Phase 3 randomized trial comparing eribulin to physician's choice in advanced non-small cell lung cancer has completed with results posted i…
-
CLINICAL_TRIALS trial_result · 2017-03-01Clinical Trial Update: Study of Blood, Tumor and Adjacent Normal Tissue Samples From Chinese Smoking Induced Lung Cancer Patients
A completed clinical trial that collected blood, tumor, and adjacent normal tissue samples from Chinese patients with smoking-induced non-sm…
-
CLINICAL_TRIALS withdrawal · 2017-02-28Clinical Trial Update: Anti-cancer MUC1-specific Immunotherapy for Unresectable Stage III Non-small Cell Lung Cancer [Phase 1]
A Phase 1 trial of a MUC1-targeted immunotherapy for unresectable stage III non-small cell lung cancer has been withdrawn, with Merck KGaA a…
-
CLINICAL_TRIALS other · 2017-02-27Clinical Trial Update: Chemotherapy Plus Bevacizumab in Elderly Non-small Cell Lung Cancer Patients [Phase 2]
Phase 2 clinical trial update evaluating chemotherapy plus bevacizumab in elderly patients with non-small cell lung cancer. The status is UN…
-
CLINICAL_TRIALS trial_result · 2017-02-24Clinical Trial Update: Preoperative Pemetrexed and Carboplatin for Select Stage IB, II, and III Non-Squamous Non-Small-Cell Lung Cancer [Phase 2]
This clinical trial update reports the completion and results posting of a Phase 2 study evaluating preoperative pemetrexed and carboplatin …
-
CLINICAL_TRIALS research · 2017-02-24Clinical Trial Update: Study of Apatinib as 3rd/4th Line Treatment in Patients With Advanced Non-Squamous Non-small Cell Lung Cancer Harboring Wild-type Epidermal Growth Factor Receptor (EGFR) [Phase 3]
Phase 3 clinical trial evaluating apatinib as a third- or fourth-line treatment for advanced non-squamous non-small cell lung cancer with wi…
-
CLINICAL_TRIALS trial_result · 2017-02-23Clinical Trial Update: Phase I Dasatinib/Erlotinib in Recurrent Non-small Cell Lung Cancer (NSCLC) [Phase 1]
This document reports the completion status of a Phase I trial evaluating the combination of dasatinib and erlotinib in adults with recurren…